EXCLUSIVE SPEAKER TOUR PRESENTATION VIDEO
Watch Dr. Timothy Hughes, a leading expert in hematology, as he discusses the evolving treatment goals and therapeutic options in chronic myelogenous leukemia (CML). Experience this presentation as if attending his May 3-6, 2018 speaker tour that was held in Calgary, Hamilton, Toronto and Quebec City.
The Changing Landscape in CML Therapy: New Treatment Goals and Choices

Timothy Hughes, MD, FRACP, FRCPA

Head of the Department of Hematology at IMVS (RAH site)
Consultant Hematologist
Royal Adelaide Hospital
Australia

VIDEOS FROM THE 58th ASH ANNUAL MEETING & EXPOSITION

Only members of HEMATOLOGY NEWSBOARD will have unlimited free access to exclusive video highlights of these interviews with renowned hematologists. Sign up now, to be among the first to know when these videos are available for viewing!

FEATURED CONTENT

Speaker tour

The Changing CML Treatment Paradigm

Giuseppe Saglio, MD, PhD
Professor of Hematology
University of Turin
Ospedale Mauriziano-Torino
Turin, Italy
2016 EHA Congress

Recent developments in the management of patients at risk of thromboembolism – from non-malignant to malignant conditions

Deborah Siegal, MD, MSc, FRCPC
Clinical Scholar, Department of Medicine
Investigator, Population Health Research Institute
McMaster University
Hamilton, Ontario, Canada
2016 EHA Congress

Results from ENESTop: Treatment-free remission following switch to Nilotinib in patients with chronic myeloid leukemia in chronic phase

Prof. Tim Hughes, MB.BS, MD, FRACP, FRCPA
Cancer Theme Leader
South Australian Health and Medical Research Institute (SAHMRI)
Beat Cancer Professor
University of Adelaide
Adelaide, South Australia